Cocrystal Accounts Payable from 2010 to 2025

COCP Stock  USD 1.48  0.08  5.13%   
Cocrystal Pharma Accounts Payable yearly trend continues to be relatively stable with very little volatility. Accounts Payable is likely to drop to about 931.8 K. Accounts Payable is the amount Cocrystal Pharma owes to suppliers or vendors for products or services received but not yet paid for. It represents Cocrystal Pharma's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2007-12-31
Previous Quarter
1.7 M
Current Value
859 K
Quarterly Volatility
665 K
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cocrystal Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cocrystal Pharma's main balance sheet or income statement drivers, such as Interest Expense of 1.7 K, Selling General Administrative of 4.1 M or Selling And Marketing Expenses of 8.9 M, as well as many indicators such as Price To Sales Ratio of 383, Dividend Yield of 0.0 or PTB Ratio of 0.69. Cocrystal financial statements analysis is a perfect complement when working with Cocrystal Pharma Valuation or Volatility modules.
  
Check out the analysis of Cocrystal Pharma Correlation against competitors.
To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.

Latest Cocrystal Pharma's Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Cocrystal Pharma over the last few years. An accounting item on the balance sheet that represents Cocrystal Pharma obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Cocrystal Pharma are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Cocrystal Pharma's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cocrystal Pharma's overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Pretty Stable
   Accounts Payable   
       Timeline  

Cocrystal Accounts Payable Regression Statistics

Arithmetic Mean887,270
Geometric Mean416,215
Coefficient Of Variation74.14
Mean Deviation493,519
Median736,279
Standard Deviation657,835
Sample Variance432.7B
Range2.6M
R-Value0.18
Mean Square Error449.1B
R-Squared0.03
Significance0.51
Slope24,517
Total Sum of Squares6.5T

Cocrystal Accounts Payable History

2025931.8 K
20241.4 M
20231.2 M
2022614 K
2021578 K
2020657 K
20191.5 M

About Cocrystal Pharma Financial Statements

Cocrystal Pharma shareholders use historical fundamental indicators, such as Accounts Payable, to determine how well the company is positioned to perform in the future. Although Cocrystal Pharma investors may analyze each financial statement separately, they are all interrelated. The changes in Cocrystal Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on Cocrystal Pharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Accounts Payable1.4 M931.8 K

Additional Tools for Cocrystal Stock Analysis

When running Cocrystal Pharma's price analysis, check to measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.